Name: Lipoproteins and Atherosclerosis (en Inglés)
SKU: 58364382
Price: 104.94 USD
Availability: InStock
Author: Malmendier, Claude L. ; Alaupovic, P.
ISBN: 9781468412703

portada Lipoproteins and Atherosclerosis (en Inglés)

Lipoproteins and Atherosclerosis (en Inglés)

Formato

Libro Físico

Autor

Claude L. Malmendier

P. Alaupovic

Editorial

Springer

Idioma

Inglés

N° páginas

256

Encuadernación

Tapa Blanda

Dimensiones

25.4x17.8x1.4 cm

Peso

0.47 kg.

ISBN13

9781468412703

Categorías

Bioquímica

Lipoproteins and Atherosclerosis (en Inglés)

Claude L. Malmendier (Autor) · P. Alaupovic (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 16 a 23 días háb.

$ 190.80$ 104.94

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 104.94

Llega entre el 22 Sep y el 05 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Lipoproteins and Atherosclerosis (en Inglés)"

Atherosclerosis which accounts in Western Europe for more than 40 % of deaths, is a generalized disease that develops slowly and is symptomless until lesions have become sufficiently severe to cause myocardial or cerebral infarction. Research on specific and precocious markers of atherosclerosis and the development of non invasive techniques for their early detection represent major challenges in biomedical field. We hope that this volume of edited papers, a consequence of the third international colloquium on atherosclerosis, conducted at the University of Brussels, Belgium through the support of the "Fondation de Recherche sur l' AtherosclE, rose" will contribute to this goal. Among the topics discussed the major ones were the mechanism of action of lipolytic enzymes, the deficiency or dysregulation of cellular receptors, the genetic deficiencies of apolipoproteins, and the panoply of external factors as diet, physical exercise, drugs, which mOdify the lipoprotein metabolism. Special interest was also devoted to potent techniques as kinetic analysis of metabolic tracers and use of monoclonal antibodies. Their contribution to the detection and treatment of atherosclerosis will be obviously essential in the future.